Back to EPRX
ROYAL BANK OF CANADA EPRX Position History
Eupraxia Pharmaceuticals Inc. • Healthcare
Quarters held
18
Latest value
$19K
Q3 2026
Peak value
$2.8M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $678K |
| Q1 2025 | $447K |
| Q2 2025 | $1.7M |
| Q2 2025 | $785K |
| Q4 2025 | $1.4M |
| Q4 2025 | $47K |
| Q4 2025 | $15K |
| Q1 2026 | $1.9M |
| Q1 2026 | $15K |
| Q2 2026 | $2M |
| Q2 2026 | $13K |
| Q2 2026 | $2M |
| Q2 2026 | $13K |
| Q2 2026 | $2M |
| Q2 2026 | $13K |
| Q3 2026 | $2K |
| Q3 2026 | $2.8M |
| Q3 2026 | $19K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $19K | 2.0K | — | — |
| Q3 2026 | $2.8M | 311.1K | — | — |
| Q3 2026 | $2K | 223 | — | — |
| Q2 2026 | $13K | 2.0K | — | — |
| Q2 2026 | $2M | 309.4K | — | — |
| Q2 2026 | $13K | 2.0K | — | — |
| Q2 2026 | $2M | 309.4K | — | — |
| Q2 2026 | $13K | 2.0K | — | — |
| Q2 2026 | $2M | 309.4K | — | — |
| Q1 2026 | $15K | 2.0K | — | — |
| Q1 2026 | $1.9M | 259.3K | — | — |
| Q4 2025 | $15K | 2.0K | — | — |
| Q4 2025 | $47K | 6.2K | — | — |
| Q4 2025 | $1.4M | 188.0K | — | — |
| Q2 2025 | $785K | 136.2K | — | — |
| Q2 2025 | $1.7M | 292.4K | — | — |
| Q1 2025 | $447K | 136.2K | — | — |
| Q1 2025 | $678K | 206.6K | — | — |